Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial - The Lancet

1. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial  The Lancet
2. Anti-viral drug trio found to shorten COVID-19 illness in mild cases: study  Yahoo News
3. A multiple sclerosis drug may speed COVID-19 recovery  Science News
4. Triple combination therapy shows promise for COVID-19 patients with less severe illnesses  ABC News
5. Triple antiviral drug shows early promise in COVID-19 trial  Yahoo News
6. View Full Coverage on Google News

(CLICK HERE TO READ AND SEE MORE)